We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

116 hedge funds and large institutions have $2.39B invested in AnaptysBio in 2017 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 41 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

643% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 7

286% more capital invested

Capital invested by funds: $620M → $2.39B (+$1.77B)

116% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 19

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

63% more funds holding

Funds holding: 71 → 116 (+45)

44% more call options, than puts

Call options by funds: $20.4M | Put options by funds: $14.2M

14% more ownership

Funds ownership: 87.17% → 101.17% (+14%)

Holders
116
Holders Change
+45
Holders Change %
+63.38%
% of All Funds
2.63%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.16%
New
52
Increased
41
Reduced
19
Closed
7
Calls
$20.4M
Puts
$14.2M
Net Calls
+$6.27M
Net Calls Change
+$6.27M

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$106M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$83.3M
3
O
OppenheimerFunds
New York
+$78M
4
BlackRock
BlackRock
New York
+$52.3M
5
State Street
State Street
Massachusetts
+$38.1M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$57.8M
2
NHAS
Novo Holdings A/S
Denmark
-$41.6M
3
PA
Perceptive Advisors
New York
-$16.6M
4
Millennium Management
Millennium Management
New York
-$10.8M
5
JP Morgan Chase
JP Morgan Chase
New York
-$8.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Artal Group
Luxembourg
$15.1M – – –
Goldman Sachs
27
Goldman Sachs
New York
$15.1M +$3.09M +42,004 +39%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$14.7M +$4.86M +66,074 +83%
RSCM
29
Rock Springs Capital Management
Maryland
$14.3M -$559K -7,600 -5%
Citigroup
30
Citigroup
New York
$13.4M +$801K +10,879 +9%
Renaissance Technologies
31
Renaissance Technologies
New York
$12.8M +$2.19M +29,700 +30%
KCM
32
Kornitzer Capital Management
Kansas
$12.8M +$9.33M +126,756 New
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$11M +$8.03M +109,097 New
TCIM
34
TIAA CREF Investment Management
New York
$10.4M +$4.5M +61,166 +145%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$9.31M +$3.99M +54,189 +142%
Invesco
36
Invesco
Georgia
$7.82M +$5.71M +77,623 New
Charles Schwab
37
Charles Schwab
California
$7.55M +$3.1M +42,094 +128%
UBS AM
38
UBS AM
Illinois
$7.19M +$5.25M +71,374 New
JP Morgan Chase
39
JP Morgan Chase
New York
$7.12M -$8.29M -112,632 -61%
Brown Advisory
40
Brown Advisory
Maryland
$6.55M +$4.79M +65,030 New
SFM
41
Soros Fund Management
New York
$6.28M +$4.59M +62,300 New
State of New Jersey Common Pension Fund D
42
State of New Jersey Common Pension Fund D
New Jersey
$5.54M – – –
KCM
43
Kennedy Capital Management
Missouri
$5.03M -$3.55M -48,167 -49%
IHM
44
Iguana Healthcare Management
New York
$4.03M -$736K -10,000 -20%
CS
45
Candriam SCA
Luxembourg
$3.98M +$2.91M +39,500 New
NIP
46
Nicholas Investment Partners
California
$3.87M +$2.83M +38,423 New
SIM
47
Spark Investment Management
New York
$3.58M -$6.32M -85,900 -71%
SFM
48
Sphera Funds Management
Israel
$3.52M -$3.31M -45,000 -56%
TA
49
Teachers Advisors
New York
$3.29M +$843K +11,456 +54%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$2.87M +$2.01M +27,253 +2,260%
1
2
3 4 5

ANAB Hedge Fund Activity: Q4 2017 in Review

116 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2017, worth a combined $2.39B — up 286% from $620M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new ANAB positions and 7 closed out — a net gain of 45 holders — while 41 added to existing stakes and 19 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $106M. The largest seller was BVF Inc, cutting an estimated $57.8M.

  • 116 institutional investors held AnaptysBio (ANAB) as of Q4 2017, up from 71 in Q3 2017.
  • Funds reported $2.39B of AnaptysBio stock for Q4 2017, up 286% quarter-over-quarter.
  • 52 funds opened new AnaptysBio positions in Q4 2017 and 7 closed out, a net change of +45 holders.
  • The largest AnaptysBio buyer in Q4 2017 was Janus Henderson Group, an estimated $106M added.
  • The largest AnaptysBio seller in Q4 2017 was BVF Inc, an estimated $57.8M sold.

Based on aggregated 13F filings for Q4 2017.